Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1 - PubMed (original) (raw)
. 2006 Jan 12;25(2):278-87.
doi: 10.1038/sj.onc.1209019.
Affiliations
- PMID: 16170359
- DOI: 10.1038/sj.onc.1209019
Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1
A Chen et al. Oncogene. 2006.
Abstract
High expression of epidermal growth factor receptor (EGFR) is found in a variety of solid tumors, including colorectal cancer. EGFR has been identified as a rational target for anticancer therapy. Curcumin, the yellow pigment of turmeric in curry, has received attention as a promising dietary supplement for cancer prevention and treatment. We recently reported that curcumin inhibited the growth of human colon cancer-derived Moser cells by suppressing gene expression of cyclinD1 and EGFR. The aim of the present study was to explore the molecular mechanisms underlying curcumin inhibition of gene expression of EGFR in colon cancer cells. The generality of the inhibitory effect of curcumin on gene expression of EGFR was verified in other human colon cancer-derived cell lines, including Caco-2 and HT-29 cells. Promoter deletion assays and site-directed mutageneses identified a binding site for the transcription factor early growth response-1 (Egr-1) in egfr promoter as a putative curcumin response element in regulating the promoter activity of the gene in Moser cells. Electrophoretic mobility shift assays demonstrated that curcumin significantly reduced the DNA-binding activity of the transcription factor Egr-1 to the curcumin response element. In addition, curcumin reduced the trans-activation activity of Egr-1 by suppressing egr-1 gene expression, which required interruption of the ERK signal pathway and reduction of the level of phosphorylation of Elk-1 and its activity. Taken together, our results demonstrated that curcumin inhibited human colon cancer cell growth by suppressing gene expression of EGFR through reducing the trans-activation activity of Egr-1. These results provided novel insights into the mechanisms of curcumin inhibition of colon cancer cell growth and potential therapeutic strategies for treatment of colon cancer.
Similar articles
- Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
Chen A, Xu J. Chen A, et al. Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G447-56. doi: 10.1152/ajpgi.00209.2004. Epub 2004 Oct 14. Am J Physiol Gastrointest Liver Physiol. 2005. PMID: 15486348 - p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.
Choi BH, Kim CG, Bae YS, Lim Y, Lee YH, Shin SY. Choi BH, et al. Cancer Res. 2008 Mar 1;68(5):1369-77. doi: 10.1158/0008-5472.CAN-07-5222. Cancer Res. 2008. PMID: 18316600 - Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma.
Normanno N, De Luca A, Salomon DS, Ciardiello F. Normanno N, et al. Cancer Detect Prev. 1998;22(1):62-7. Cancer Detect Prev. 1998. PMID: 9466051 Review. - Efficacy of ligand-based targeting for the EGF system in cancer.
Yotsumoto F, Sanui A, Fukami T, Shirota K, Horiuchi S, Tsujioka H, Yoshizato T, Kuroki M, Miyamoto S. Yotsumoto F, et al. Anticancer Res. 2009 Nov;29(11):4879-85. Anticancer Res. 2009. PMID: 20032451 Review.
Cited by
- The putative oncotarget CSN5 controls a transcription-uncorrelated p53-mediated autophagy implicated in cancer cell survival under curcumin treatment.
Zhang QY, Jin R, Zhang X, Sheng JP, Yu F, Tan RX, Pan Y, Huang JJ, Kong LD. Zhang QY, et al. Oncotarget. 2016 Oct 25;7(43):69688-69702. doi: 10.18632/oncotarget.11940. Oncotarget. 2016. PMID: 27626169 Free PMC article. - Nutrient-Gene Interaction in Colon Cancer, from the Membrane to Cellular Physiology.
Hou TY, Davidson LA, Kim E, Fan YY, Fuentes NR, Triff K, Chapkin RS. Hou TY, et al. Annu Rev Nutr. 2016 Jul 17;36:543-70. doi: 10.1146/annurev-nutr-071715-051039. Annu Rev Nutr. 2016. PMID: 27431370 Free PMC article. Review. - Comparative analysis of the chrysanthemum transcriptome with DNA methylation inhibitors treatment and silencing MET1 lines.
Kang D, Khan MA, Song P, Liu Y, Wu Y, Ai P, Li Z, Wang Z. Kang D, et al. BMC Plant Biol. 2023 Jan 21;23(1):47. doi: 10.1186/s12870-023-04036-x. BMC Plant Biol. 2023. PMID: 36670371 Free PMC article. - A synergistic antiproliferation effect of curcumin and docosahexaenoic acid in SK-BR-3 breast cancer cells: unique signaling not explained by the effects of either compound alone.
Altenburg JD, Bieberich AA, Terry C, Harvey KA, Vanhorn JF, Xu Z, Jo Davisson V, Siddiqui RA. Altenburg JD, et al. BMC Cancer. 2011 Apr 21;11:149. doi: 10.1186/1471-2407-11-149. BMC Cancer. 2011. PMID: 21510869 Free PMC article. - Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment.
Teiten MH, Eifes S, Dicato M, Diederich M. Teiten MH, et al. Toxins (Basel). 2010 Jan;2(1):128-62. doi: 10.3390/toxins2010128. Epub 2010 Jan 21. Toxins (Basel). 2010. PMID: 22069551 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous